SCHEMBL19982672

SCHEMBL19982672

CC(C)c1cc(Cc2c(Cl)cc(C(=N)CP(=O)(O)O)cc2Cl)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRA P10827 11/20 0.40
THRB P10828 11/20 0.40
SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328372 0.88 THRB (0.43) THRATHRBSMN1; SMN2
SCHEMBL13381676 0.83 THRB (0.43) THRATHRBSMN1; SMN2
SCHEMBL328509 0.79 THRB (0.59) THRATHRB
SCHEMBL283411 0.77 THRB (0.49) THRATHRB
SCHEMBL13381669 0.76 THRB (0.53) THRATHRB
SCHEMBL328293 0.75 THRB (0.52) THRATHRB
SCHEMBL283129 0.71 THRB (0.76) THRATHRB
SCHEMBL13381667 0.70 THRB (0.49) THRATHRB
SCHEMBL3748866 0.70 THRB (0.49) THRATHRB
SCHEMBL4212904 0.68 THRA (0.76) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018053036-A1 METHOD OF REDUCING THYROID-ASSOCIATED SIDE EFFECTS VIKING THERAPEUTICS, INC. (US) 2018-03-22 WO disclosed